ClassID:

21481

A61K49/103 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA

Sub-classes:
Recent Application in this class:
#1
20250271525
2025-08-28

SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS

#2
20250271524
2025-08-28

METHODS FOR PROTON-ONLY DETECTION OF HYPERPOLARIZED HETERONUCLEAR SINGLET STATES

#3
20250121100
2025-04-17

COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING

#4
20240225448
2024-07-11

CHARACTERISING LESIONS IN THE LIVER USING DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE TOMOGRAPHY

#5
20240139348
2024-05-02

MULTI-MODALITY MOLECULAR IMAGING PROBE, AND PREPARATION METHOD AND USE THEREOF

#6
20230406873
2023-12-21

PROBES, SYSTEMS, AND METHODS FOR MAGNETIC RESONANCE PH SENSING

#7
20230329558
2023-10-19

METHOD FOR MULTIMODAL TISSUE IMAGING BASED ON RESONANCE RAMAN EFFECT ON METAL BASED MRI CONTRAST AGENTS AND METHOD FOR IONIZING LASER PLUMES THROUGH ATMOSPHERIC PRESSURE CHEMICAL IONIZATION

#8
20230098403
2023-03-30

MAGNETIC RESONANCE IMAGING CONTRAST AGENT, PREPARATION METHOD AND USE THEREOF

#9
20220409145
2022-12-29

GENERATION OF MRI IMAGES OF THE LIVER WITHOUT CONTRAST ENHANCEMENT

#10
20220211879
2022-07-07

SOLVENT FREE GADOLINIUM CONTRAST AGENTS

#11
20210330823
2021-10-28

Methods for Cell Labeling and Medical Imaging

#12
20210154333
2021-05-27

Polarisation transfer via a second metal complex

#13
20210015948
2021-01-21

Manganese-based chelate conjugates for molecular MR imaging

#14
20200390965
2020-12-17

Tailored dose of contrast agent

#15
20200371183
2020-11-26

Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices

#16
20200129645
2020-04-30

CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING

#17
20200071341
2020-03-05

Preparation of a solid form of gadobenate dimeglumine

#18
20190365933
2019-12-05

Solvent-free gadolinium contrast agents

#19
20190317171
2019-10-17

Method for joint arterial input function and tracer kinetic parameter estimation in accelerated DCE-MRI using a model consistency constraint

#20
20190269329
2019-09-05

Method for multimodal tissue imaging based on resonance Raman effect on metal based MRI contrast agents and method for ionizing laser plumes through atmospheric pressure chemical ionization

#21
20190247523
2019-08-15

Gadolinium contrast agents, scavenging methods, and scavenging system

#22
20190231907
2019-08-01

Metal complexes with bisphophonate or pyrophosphate useful as imaging agents

#23
20190192420
2019-06-27

USE OF A REVERSE-MICELLAR SYSTEM FOR DELIVERING CHELATORS OF RADIONUCLIDES AND METALS

#24
20190184036
2019-06-20

Cell-permeable imaging sensors and uses thereof

#25
20190111160
2019-04-18

Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents

#26
20190094323
2019-03-28

SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS

#27
20190001003
2019-01-03

Manganese-based chelate conjugates for molecular MR imaging

#28
20180185521
2018-07-05

Solvent-Free Gadolinium Contrast Agents

#29
20180078660
2018-03-22

Crystalline contrast agent for magnetic resonance imaging, kit and composition comprising it and their use

#30
20180043041
2018-02-15

Methods for cell labeling and medical imaging

#31
20180036436
2018-02-08

Ethylenediaminetetraacetic acid bis(amide) derivatives and their respective complexes with Mn(II) ion for use as MRI contrast agent

#32
20170189562
2017-07-06

Metal complexes with bisphosphonate useful as imaging agents

#33
20170143853
2017-05-25

MRI signal suppression agents, compositions, and methods

#34
20170079581
2017-03-23

MRI-guided intraarterial catheter-based method for predicting territory of local blood brain barrier opening

#35
20170057986
2017-03-02

Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species

#36
20170035909
2017-02-09

Use of a reverse-micellar system for delivering chelators of radionuclides and metals

#37
20170029386
2017-02-02

N-alkoxyamide conjugates as imaging agents

#38
20170014108
2017-01-19

Systems and methods for extracting prognostic image features

#39
20160274208
2016-09-22

System and method for magnetic resonance imaging

#40
20160193337
2016-07-07

Iron-salen complex

#41
20160185737
2016-06-30

N-alkoxyamide conjugates as imaging agents

#42
20160136305
2016-05-19

Cobalt-based MRI contrast agent and imaging system

#43
20160008496
2016-01-14

Imaging diagnostics by combining contrast agents

#44
20150346304
2015-12-03

Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices

#45
20150336997
2015-11-26

Manganese-based magnetic resonance contrast agents

#46
20150320888
2015-11-12

Nuclear magnetic resonance diagnostic agent, and method for detecting or diagnosing state of cell, tissue or organ in subject using same

#47
20150238639
2015-08-27

Contrast Agent and Applications Thereof

#48
20150139914
2015-05-21

Contrast agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water

#49
20150094465
2015-04-02

N-alkoxyamide conjugates as imaging agents

#50
20140349004
2014-11-27

DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME

#51
20140323566
2014-10-30

Self-magnetic metal-salen complex compound

#52
20140127135
2014-05-08

Lipidomimetic compounds and uses thereof

#53
20140088314
2014-03-27

BIFUNCTIONAL CHELATING AGENTS

#54
20140065076
2014-03-06

CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME

#55
20140005369
2014-01-02

Uridine-based gadolinium complex and MRI contrast agent including the same

#56
20130315822
2013-11-28

N-alkoxyamide conjugates as imaging agents

#57
20130190605
2013-07-25

Methods and compositions for objectively characterizing medical images

#58
20130101514
2013-04-25

Compositions and methods for treating nephropathy

#59
20120302514
2012-11-29

GLYCOCONJUGATES AND METHODS

#60
20120226048
2012-09-06

Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same

#61
20120189551
2012-07-26

MRI markers, delivery and extraction systems, and methods of manufacture and use thereof

#62
20120128583
2012-05-24

DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME

#63
20120121509
2012-05-17

VITAL FLUOROCHROME CONJUGATES AND METHODS OF USE

#64
20120107249
2012-05-03

Diagnostic imaging contrast agents with extended blood retention

#65
20120093735
2012-04-19

Complex compound and MRI probe made of same

#66
20110279117
2011-11-17

System and method for magnetic resonance imaging

#67
20110245512
2011-10-06

Hydroxylated contrast enhancement agents

#68
20110243858
2011-10-06

Hydroxylated contrast enhancement agents and imaging method

#69
20110243847
2011-10-06

IMAGING DIAGNOSTICS BY COMBINING CONTRAST AGENTS

#70
20110165089
2011-07-07

Complex Compound and MRI Probe Made of Same

#71
20110117015
2011-05-19

Diagnostic agents selective against metalloproteases

#72
20110077396
2011-03-31

INTERMEDIATES FOR HYDROXYLATED CONTRAST ENHANCEMENT AGENTS

#73
20110076237
2011-03-31

Hydroxylated contrast enhancement agents

#74
20110065959
2011-03-17

Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography

#75
20110002853
2011-01-06

Use of the spin crossover complex [m(L)H]AN)as a magnetic resonance imaging contrast agent

#76
20100297019
2010-11-25

Particles for imaging

#77
20100247448
2010-09-30

NOVEL LANTHANIDE LIGANDS AND COMPLEXES, AND USE THEREOF AS CONTRAST AGENTS

#78
20100191097
2010-07-29

Method of hyperpolarising a magnetic resonance agent

#79
20100166667
2010-07-01

Magnetic resonance imaging

#80
20100092396
2010-04-15

Hyperpolarized 89-yttrium and methods relating thereto

#81
20100056787
2010-03-04

Chelating agents

#82
20090317325
2009-12-24

Diagnostic substance and method for the analysis of metabolism processes in the brain

#83
20090297454
2009-12-03

Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use

#84
20090252676
2009-10-08

N-alkoxyamide conjugates as imaging agents

#85
20090246141
2009-10-01

Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure

#86
20090214437
2009-08-27

In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging

#87
20090169484
2009-07-02

IRON-SALEN COMPLEX

#88
20090169479
2009-07-02

Compounds comprising short aminoalcohol chains and metal complexes for medical imaging

#89
20090155184
2009-06-18

Method of magnetic resonance imaging of the heart with paramagnetic MN

#90
20090023928
2009-01-22

PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS

#91
20080176339
2008-07-24

NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF

#92
20080145311
2008-06-19

Chelating agents with lipophilic carriers

#93
20080081021
2008-04-03

Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation

#94
20070269384
2007-11-22

Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease

#95
20070207087
2007-09-06

Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes

#96
20070202047
2007-08-30

Polyamine-substituted ligands for use as contrast agents

#97
20070189969
2007-08-16

Perfluoroalkyl-containing complexes, process for their production as well as their use

#98
20070166228
2007-07-19

Neutral labeling reactants and conjugates derived thereof

#99
20070065520
2007-03-22

Mri contrast medium composition for oral administration

#100
20070020185
2007-01-25

Diagnostic imaging contrast agents with extended blood retention

#101
20070020184
2007-01-25

Diagnostic imaging contrast agents with extended blood retention

#102
20070020183
2007-01-25

Perfluoroalkyl-containing complexes, process for their production as well as their use

#103
20070003484
2007-01-04

Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules

#104
20070003479
2007-01-04

Diagnostic imaging contrast agents with extended blood retention

#105
20060292079
2006-12-28

Conjugates of hydroxypyridinone derivative metal complexes with biomolecules and their use for MRI diagnosis

#106
20060275217
2006-12-07

Chemical exchange saturation transfer contrast agents

#107
20060275216
2006-12-07

Bioactivated diagnostic imaging contrast agents

#108
20060257322
2006-11-16

Pharmaceutical agents that contain fluoroalkyl-containing metal complexes and epothilones

#109
20060251583
2006-11-09

DTPA derivatives and metal complexes thereof, and radiation source and contrast agent including the metal complexes

#110
20060235292
2006-10-19

Magnetic resonance imaging method and compounds for use in the method

#111
20060210478
2006-09-21

Steady state perfusion methods

#112
20060193781
2006-08-31

Magnetic resonance imaging of metal concentrations

#113
20060057071
2006-03-16

Paramagnetic complexes with pendant crown compounds showing improved targeting-specificity as MRI contrast agents

#114
20060034774
2006-02-16

Galactopyrannosyltriaminetetracarboxylate as ligands for bioactivated paramagnetic metal complexes

#115
20050282271
2005-12-22

Glycoconjugates and methods

#116
20050201930
2005-09-15

Contrast agents

#117
20050118103
2005-06-02

Contrast-enhanced diagnostic imaging method for monitoring interventional therapies

#118
20050058604
2005-03-17

Phthalamide-lanthanide complexes for use as luminescent markers

#119
20050058601
2005-03-17

Polypodal chelants for metallopharmaceuticals

#120
20050008570
2005-01-13

Hydroxypyridonate and hydroxypyrimidinone chelating agents

#121
20050002866
2005-01-06

Magnetic resonance imaging agents for the detection of physiological agents